QTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
QT Imaging Holdings Inc (QTI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, promising analyst ratings, and significant potential in breast cancer screening make it an attractive long-term investment despite short-term technical weakness.
The MACD histogram is slightly negative (-0.01), indicating weak momentum. The RSI is at 28.62, close to oversold territory but still neutral. Moving averages are converging, suggesting indecision in the market. Key resistance levels are at $0.54 and $0.58, while support levels are at $0.41 and $0.36. Overall, technical indicators do not suggest a strong immediate trend.
Analysts have initiated coverage with a Buy rating and a $10 price target, citing the company's unique 3D imaging technology and potential in breast cancer screening.
Record revenue growth in Q4 2025, with a 97% QoQ increase and 877% YoY growth.
Positive revenue projection of $39 million for 2026, indicating strong growth potential.
The company reported a Q4 net loss of $1.387 million, indicating ongoing profitability challenges.
Gross margin dropped YoY, reflecting potential cost pressures.
QT Imaging achieved record revenue of $8.3 million in Q4 2025, marking a 97% QoQ and 877% YoY growth. Annual revenue for 2025 reached $18.9 million, exceeding guidance and showing a 288% increase from 2024. However, the company reported a net loss of $1.387 million in Q4 2025, and gross margin declined YoY.
Lake Street initiated coverage with a Buy rating and a $10 price target, highlighting the company's unique technology and significant potential in breast cancer screening.
